# tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

> **NCT05517135** · — · RECRUITING · sponsor: **National Cancer Centre, Singapore** · enrollment: 1000 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **OTHER:** Arm 1
- **OTHER:** Arm 2
- **OTHER:** Arm 3
- **OTHER:** Group 1
- **OTHER:** Group 2

## Key facts

- **NCT ID:** NCT05517135
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-17
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05517135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05517135, "tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05517135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*